project id: TCGA-SKCM; case submitter id: TCGA-FS-A4FD; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 9.4; age at index: 39; days to birth: -14426; days to death: 2454; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1965; age at diagnosis: 14426; ajcc pathologic m: M0; ajcc pathologic n: N3; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2369.0; icd 10 code: C77.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: Yes; progression or recurrence: not reported; site of resection or biopsy: Lymph node, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2004; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; initial weight: 80.0; oct embedded: false; preservation method: Unknown; sample id: 368856fa-f513-448e-a65c-cd61b1bb798a; sample submitter id: TCGA-FS-A4FD-06A; portion id: 11963a81-2f57-4aa3-bfa3-a7bfe1f5e038; portion submitter id: TCGA-FS-A4FD-06A-11; slide id: f713d7a0-56cb-437c-a36c-e7442e51447b; slide submitter id: TCGA-FS-A4FD-06A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0; section location: TOP;